Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate plus methotrexate versus methotrexate alone in active rheumatoid arthritis
ChiCTR-TRC-09000473Phase 4Completed
- Sponsor
- Peking University People's Hospital
- Start
- Jul 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in rheumatoid arthritis (RA) comparing MTX + alendronate with MTX alone (2 arms). Primary endpoint: SHARP score. Started Jul 2009; status: completed.
02
Drugs
alendronatemethotrexate
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ChiCTR-TRC-09000473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000473.